Shareholding disclosure
Santhera Pharmaceuticals Holding AG
Declared position
71.8%
Threshold
Crossed downwards
Timeline
Published
29.10.2020
Transaction
21.10.2020
Voting rights breakdown
Voting rights acquired8.46%
Voting rights sold71.8%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
TAKAR00032
Beneficial owner
Santhera Pharmaceuticals Holding AG
Declared address
Santhera Pharmaceuticals Holding AG, Pratteln
Acquisition and disposal of shares on October 21, 2020; also regarding certain sales positions
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open